Microbial-host interactions: selecting the right probiotics and prebiotics for infants - PubMed (original) (raw)
. 2009:64:201-13; discussion 213-7, 251-7.
doi: 10.1159/000235792. Epub 2009 Aug 19.
Affiliations
- PMID: 19710524
- DOI: 10.1159/000235792
Microbial-host interactions: selecting the right probiotics and prebiotics for infants
Seppo Salminen et al. Nestle Nutr Workshop Ser Pediatr Program. 2009.
Abstract
Probiotics were originally used to influence human health through intestinal microbiota alterations. At present, probiotics and their effects on human health have been demonstrated both within different food matrices and as single or mixed culture preparations. The health-promoting properties are known to be strain-dependent. Thus, strain identification and characterization are important: only well-characterized strains identified with modern techniques are acceptable, especially if health claims are desired. Linking the strain to a specific health effect as well as to enable accurate surveillance and epidemiological studies are important targets. Currently there are specific strains which have demonstrated beneficial in vitro properties and clinically proven health benefits. Such specific probiotics have been included in recommendations on pediatric nutrition. The model is the microbiota of the healthy breastfed infant. Molecular methods in microbiota assessment enable more specific probiotics and prebiotics to be identified for infants with aberrancies in intestinal microbiota. Probiotic products require information on the concentration and viability of the strain(s) in the product as well as data on required dosages. Continuous control of probiotic strains or strain combinations is a must as small changes in production process or growth media may significantly affect the properties of a strain or strain combination.
Copyright 2009 Nestec Ltd., Vevey/S. Karger AG, Basel.
Similar articles
- Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
Isolauri E, Salminen S; Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report. Isolauri E, et al. J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S91-6. doi: 10.1097/MCG.0b013e3181639a98. J Clin Gastroenterol. 2008. PMID: 18542035 Review. - Probiotics and prebiotics: immunological and clinical effects in allergic disease.
Tang ML. Tang ML. Nestle Nutr Workshop Ser Pediatr Program. 2009;64:219-35; discussion 235-8, 251-7. doi: 10.1159/000235793. Epub 2009 Aug 19. Nestle Nutr Workshop Ser Pediatr Program. 2009. PMID: 19710525 - Probiotics, prebiotics, and synbiotics.
de Vrese M, Schrezenmeir J. de Vrese M, et al. Adv Biochem Eng Biotechnol. 2008;111:1-66. doi: 10.1007/10_2008_097. Adv Biochem Eng Biotechnol. 2008. PMID: 18461293 Review. - Intestinal colonisation, microbiota and future probiotics?
Salminen S, Benno Y, de Vos W. Salminen S, et al. Asia Pac J Clin Nutr. 2006;15(4):558-62. Asia Pac J Clin Nutr. 2006. PMID: 17077076 Review. - Probiotics and prebiotics in pediatrics.
Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Thomas DW, et al. Pediatrics. 2010 Dec;126(6):1217-31. doi: 10.1542/peds.2010-2548. Epub 2010 Nov 29. Pediatrics. 2010. PMID: 21115585 Review.
Cited by
- The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.
Renz H, Brandtzaeg P, Hornef M. Renz H, et al. Nat Rev Immunol. 2011 Dec 9;12(1):9-23. doi: 10.1038/nri3112. Nat Rev Immunol. 2011. PMID: 22158411 Review. - Does Probiotic Consumption Enhance Wound Healing? A Systematic Review.
Togo C, Zidorio AP, Gonçalves V, Botelho P, de Carvalho K, Dutra E. Togo C, et al. Nutrients. 2021 Dec 27;14(1):111. doi: 10.3390/nu14010111. Nutrients. 2021. PMID: 35010987 Free PMC article. - Evidence-based guidelines for use of probiotics in preterm neonates.
Deshpande GC, Rao SC, Keil AD, Patole SK. Deshpande GC, et al. BMC Med. 2011 Aug 2;9:92. doi: 10.1186/1741-7015-9-92. BMC Med. 2011. PMID: 21806843 Free PMC article. Review. - Reduced-Fat Response of Lactobacillus casei subsp. casei SY13 on a Time and Dose-Dependent Model.
Jia Z, Pang X, Lv J. Jia Z, et al. Front Microbiol. 2018 Dec 21;9:3200. doi: 10.3389/fmicb.2018.03200. eCollection 2018. Front Microbiol. 2018. PMID: 30619236 Free PMC article. - Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
McFarland LV. McFarland LV. World J Gastroenterol. 2010 May 14;16(18):2202-22. doi: 10.3748/wjg.v16.i18.2202. World J Gastroenterol. 2010. PMID: 20458757 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical